FI904445A7 - Viruksenvastaisia yhdisteitä - Google Patents

Viruksenvastaisia yhdisteitä Download PDF

Info

Publication number
FI904445A7
FI904445A7 FI904445A FI904445A FI904445A7 FI 904445 A7 FI904445 A7 FI 904445A7 FI 904445 A FI904445 A FI 904445A FI 904445 A FI904445 A FI 904445A FI 904445 A7 FI904445 A7 FI 904445A7
Authority
FI
Finland
Prior art keywords
antiviral compounds
antiviral
compounds
Prior art date
Application number
FI904445A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI904445A0 (fi
Inventor
Thomas Anthony Krenitsky
Tuttle Joel Van
Sylvia Margaret Tisdale
Martin John Slater
Wayne Howard Miller
George Walter Koszalka
Susan Mary Daluge
Original Assignee
The Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wellcome Foundation Ltd filed Critical The Wellcome Foundation Ltd
Publication of FI904445A0 publication Critical patent/FI904445A0/fi
Publication of FI904445A7 publication Critical patent/FI904445A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Local Oxidation Of Silicon (AREA)
  • Element Separation (AREA)
FI904445A 1989-09-11 1990-09-10 Viruksenvastaisia yhdisteitä FI904445A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898920534A GB8920534D0 (en) 1989-09-11 1989-09-11 Antiviral compounds

Publications (2)

Publication Number Publication Date
FI904445A0 FI904445A0 (fi) 1990-09-10
FI904445A7 true FI904445A7 (fi) 1991-03-12

Family

ID=10662891

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904445A FI904445A7 (fi) 1989-09-11 1990-09-10 Viruksenvastaisia yhdisteitä

Country Status (19)

Country Link
EP (2) EP0417999B1 (enExample)
JP (1) JPH03145497A (enExample)
KR (1) KR910006293A (enExample)
AT (1) ATE135365T1 (enExample)
AU (1) AU644095B2 (enExample)
CA (1) CA2025009A1 (enExample)
DD (1) DD297650A5 (enExample)
DE (1) DE69025834D1 (enExample)
FI (1) FI904445A7 (enExample)
GB (1) GB8920534D0 (enExample)
HU (1) HUT54704A (enExample)
IE (1) IE903269A1 (enExample)
MY (1) MY130035A (enExample)
NZ (1) NZ235244A (enExample)
PL (1) PL164967B1 (enExample)
PT (1) PT95261A (enExample)
RU (2) RU2043361C1 (enExample)
TW (2) TW226333B (enExample)
ZA (1) ZA907187B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95384C (fi) * 1989-04-06 1996-01-25 Squibb Bristol Myers Co Menetelmä 3'-deoksi-3'-substituoitujen metyylinukleosidien valmistamiseksi ja menetelmässä käytettäviä välituotteita
US5859221A (en) * 1990-01-11 1999-01-12 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US5914396A (en) * 1990-01-11 1999-06-22 Isis Pharmaceuticals, Inc. 2'-O-modified nucleosides and phosphoramidites
US6399754B1 (en) 1991-12-24 2002-06-04 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides
US5670633A (en) * 1990-01-11 1997-09-23 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides that detect and modulate gene expression
US5872232A (en) * 1990-01-11 1999-02-16 Isis Pharmaceuticals Inc. 2'-O-modified oligonucleotides
US6005087A (en) * 1995-06-06 1999-12-21 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
WO1991015498A2 (en) * 1990-04-04 1991-10-17 Nycomed Imaging As Nucleoside derivatives
US5623070A (en) * 1990-07-27 1997-04-22 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5618704A (en) * 1990-07-27 1997-04-08 Isis Pharmacueticals, Inc. Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling
US5792844A (en) * 1990-07-27 1998-08-11 Isis Pharmaceuticals, Inc. Oligonucleoside linkages containing adjacent nitrogen atoms
US5677437A (en) * 1990-07-27 1997-10-14 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5378825A (en) * 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US5610289A (en) 1990-07-27 1997-03-11 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogues
WO1992011276A1 (en) * 1990-12-18 1992-07-09 Sloan-Kettering Institute For Cancer Research Novel synthesis of 2'-'up' fluorinated 2''-deoxy-arabinofuranosylpurines
US5672697A (en) * 1991-02-08 1997-09-30 Gilead Sciences, Inc. Nucleoside 5'-methylene phosphonates
US5965722A (en) * 1991-05-21 1999-10-12 Isis Pharmaceuticals, Inc. Antisense inhibition of ras gene with chimeric and alternating oligonucleotides
US7119184B2 (en) 1991-08-12 2006-10-10 Isis Pharmaceuticals, Inc. Oligonucleotides having A-DNA form and B-DNA form conformational geometry
US6307040B1 (en) 1992-03-05 2001-10-23 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides that detect and modulate gene expression
US5393841A (en) * 1993-11-09 1995-02-28 Shell Oil Company Dissimilar arm asymmetric radial or star block copolymers for adhesives and sealants
US6413410B1 (en) 1996-06-19 2002-07-02 Lifescan, Inc. Electrochemical cell
US9096636B2 (en) 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
PT917879E (pt) * 1997-11-22 2002-12-31 Roche Diagnostics Gmbh Processo melhorado para estabilizacao de proteinas
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
US6348587B1 (en) * 1998-02-25 2002-02-19 Emory University 2′-Fluoronucleosides
EP1411954B1 (en) 2000-10-18 2010-12-15 Pharmasset, Inc. Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
US7132453B2 (en) * 2002-03-15 2006-11-07 Vanderbilt University Method of using prostacyclin to treat respiratory syncytial virus infections
US8604183B2 (en) 2002-11-05 2013-12-10 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
WO2008109080A2 (en) * 2007-03-01 2008-09-12 Siemens Medical Solutions Usa, Inc. Nucleoside based proliferation imaging markers
EP2669290A1 (en) 2009-03-02 2013-12-04 Alnylam Pharmaceuticals Inc. Nucleic Acid Chemical Modifications
WO2011123621A2 (en) 2010-04-01 2011-10-06 Alnylam Pharmaceuticals Inc. 2' and 5' modified monomers and oligonucleotides
EP2937420A1 (en) * 2014-04-23 2015-10-28 Synbias Pharma AG Method for the synthesis of clofarabine
WO2018110643A1 (ja) * 2016-12-14 2018-06-21 ヤマサ醤油株式会社 抗ウイルス活性を示すヌクレオシド誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
CA1340645C (en) * 1987-04-17 1999-07-13 Victor E. Marquez Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus

Also Published As

Publication number Publication date
ATE135365T1 (de) 1996-03-15
CA2025009A1 (en) 1991-03-12
PL286820A1 (en) 1991-04-22
PL164967B1 (pl) 1994-10-31
DD297650A5 (de) 1992-01-16
JPH03145497A (ja) 1991-06-20
IE903269A1 (en) 1991-03-27
EP0671410A1 (en) 1995-09-13
GB8920534D0 (en) 1989-10-25
TW226333B (enExample) 1994-07-11
EP0417999B1 (en) 1996-03-13
AU6235090A (en) 1991-03-14
MY130035A (en) 2007-05-31
DE69025834D1 (de) 1996-04-18
NZ235244A (en) 1992-11-25
TW246641B (enExample) 1995-05-01
AU644095B2 (en) 1993-12-02
EP0417999A1 (en) 1991-03-20
ZA907187B (en) 1992-05-27
HUT54704A (en) 1991-03-28
FI904445A0 (fi) 1990-09-10
KR910006293A (ko) 1991-04-29
RU94002475A (ru) 1996-11-10
PT95261A (pt) 1991-05-22
RU2043361C1 (ru) 1995-09-10

Similar Documents

Publication Publication Date Title
FI904445A7 (fi) Viruksenvastaisia yhdisteitä
FI906113A7 (fi) Viruksenvastaiset yhdisteet
FI901903A7 (fi) Viruksenvastaisia aineita
CY2008001I2 (el) Antiviral compounds
ID996B (id) Pirrolum tersubstitusi
DK0406185T3 (da) Fluidbedovn
NO170236C (no) Lineaermotor
DE69028192D1 (de) Ablenkjoch
NO920091D0 (no) Presse-apparat
FI89684C (fi) Riktdon foer bilkarosseri
FI904138A7 (fi) Pyrrolikinoliiniyhdisteet
FI930833A0 (fi) Traeningsfoerfarande och -artiklar
DK0423802T3 (da) Phenoxyheterocycliske forbindelser
FI905860A0 (fi) Magnesiumkäsittelymenetelmä
FI895572A7 (fi) Virusvastaisia yhdisteitä
IT9020177A0 (it) Bombesin-antagonisti
FI902130A0 (fi) Paraboloidiheijastinantenni
DE69026319D1 (de) Substituierte Phenylalkylimidazol-Verbindungen
FR2644997B1 (fr) Estrade-lit
DK551789D0 (da) Laessekran
BR1100245A (pt) Compostos benzoeterocìclicos
BR1100785A (pt) Compostos de alcoxiiminoacetamida
KR900019761U (ko) 휴대품 보관 케이스
IT218982Z2 (it) Custodia per densatore
IT216914Z2 (it) Portaritratti

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: THE WELLCOME FOUNDATION LIMITED